Top 10 Best Practices for Successfully Obtaining Second Round of Funding for Biotech Startups

August 31, 2023

Small business team collaborating in conference room at night

Securing funding is a crucial milestone for biotech startups aiming to advance their research and bring innovative products to market. Once the initial round of funding is secured, the next challenge lies in obtaining a second round of funding to sustain the research and development process. In this blog post, we will outline the top 10 best practices specifically tailored for biotech startups to successfully obtain a second round of funding.

1. Show Progress Since First Funding Round

Biotech startups must showcase the progress they have made since their first funding round to secure a second round of funding. This includes milestones achieved, scientific breakthroughs, and progress in pre-clinical or clinical trials. By showcasing progress, startups can prove to investors that they are making strides in their research and development efforts.

2. Highlight Strong Intellectual Property

Biotech startups should avoid the common mistake of overlooking the significance of intellectual property (IP) when crafting their IND development plan, as strong IP is a valuable asset that can attract investors for the second funding round. Biotech startups should highlight their patents, trade secrets, and other IP assets that provide a competitive advantage.

3. Build a Strong Management Team

Biotech startups should build a strong management team with the experience and capability to execute plans and bring products to market, which investors seek. Ensuring that the management team has the necessary expertise and experience to lead the company to success.

4. Develop a Clear and Comprehensive Business Plan

Biotech startups must develop a clear and comprehensive business plan to secure a second round of funding. The plan should outline the company’s goals, milestones, and timelines, as well as a detailed financial forecast. Biotech startups should be transparent and realistic about their financial projections and show investors how their product will generate revenue.

5. Seek Out Strategic Partnerships

Biotech startups should seek out strategic partnerships to secure a second round of funding, as these partnerships provide access to resources, expertise, and funding. By seeking out partnerships with universities, research institutions, and industry partners to help advance their research and development efforts.

6. Demonstrate Market Potential

Biotech startups need to demonstrate the market potential for their product to attract investors. By demonstrating the potential market size and demand for their product by conducting market research, analyzing industry trends, and identifying potential competitors.

7. Address Regulatory Requirements

Biotech startups should be aware of the regulatory requirements for their product and demonstrate to investors that they have a solid plan to meet these requirements. This includes obtaining necessary approvals, conducting clinical trials, and meeting safety and efficacy standards.

8. Demonstrate Financial Discipline

Biotech startups should demonstrate financial discipline by managing their expenses and showing investors that they are operating efficiently. This includes developing a detailed budget and sticking to it, as well as using resources wisely.

9. Be Transparent and Communicative

Biotech startups should prioritize transparency and effective communication to secure a second round of funding. By being transparent about their progress, challenges, and financial situation, and keep investors informed about developments in their research and development efforts.

10. Network and Build Relationships

Finally, biotech startups should actively network and build relationships with investors, industry leaders, and other key stakeholders. This includes attending industry events, conferences, and networking opportunities to build connections and establish partnerships.


For experienced guidance and expert consultation on securing a second round of funding in the biotech industry, reach out to the ProPharma team today. Our knowledgeable experts can provide valuable insights and support to help you navigate the complex landscape of funding opportunities and drive your biotech startup towards further growth and success. Contact us now to discuss your specific needs and goals.

Contact Us


FDA Warns of Serious Side Effects Associated with Fluoroquinolone Antibacterial Drugs

On Thursday, May 12th, the FDA issued a warning regarding fluoroquinolone antibacterial drugs, stating that the associated side effects “generally outweigh the benefits for patients with sinusitis,...

December 16, 2015

The FDA’s Enforcement of Section 503B of the Federal Food, Drug, and Cosmetic Act

The FDA publishes weekly enforcement reports highlighting drugs that have been recalled during the previous week. Over the past several months these reports have been littered with hundreds of...

FDA Outlines Policies for Compounding Drug Products That Are Essentially Copies of Approved Drugs Under Section 503B of the FD&C Act

In our preceding FDA News article, we focused on the content of the first draft guidance, which addresses restrictions concerning the compounding of drug products that are essentially copies of...